PURPOSE: We examined the associations between plasma micronutrients and bladder cancer risk, and evaluated the combined effects of carotenoid and cigarette smoke. MATERIALS AND METHODS: We performed a case-control study in 242 patients with bladder cancer and 204 healthy controls at Memorial Sloan-Kettering Cancer Center from 1993 to 1997. Epidemiological data and blood specimens were collected on 84 cases and 173 controls. Plasma micronutrients, including lutein, zeaxanthin, beta-cryptoxanthin, lycopene, alpha-carotene, beta-carotene, retinol, alpha-tocopherol and gamma-tocopherol, were determined by high performance liquid chromatography. The logistic regression model was used to estimate the effects from carotenoid, tocopherol and retinol on the risk of bladder cancer. RESULTS: Based on quartiles of plasma micronutrient levels and continuous variables, adjusted ORs were estimated for bladder cancer after controlling for potential confounders, including patient age, sex, education and pack-years of smoking. When using plasma levels of micronutrients as continuous variables, the adjusted OR was 0.22 (95% CI 0.05 to 0.92) for alpha-carotene, 0.42 (95% CI 0.18 to 1.00) for lutein, 0.16 (95% CI 0.02 to 1.06) for zeaxanthin, 0.94 (95% CI 0.89 to 0.99) for lycopene and 0.90 (95% CI 0.81 to 1.00) for beta-cryptoxanthin. The adjusted OR for the joint effect of plasma carotenoids and tobacco smoking was 6.22 (95% CI 1.87 to 20.8) in smokers with lower lutein and 5.18 (95% CI 1.57 to 17.1) in smokers with lower zeaxanthin. CONCLUSIONS: Our results show protective effects of carotenoids on bladder cancer. They suggest that bladder cancer may be a preventable disease through nutritional intervention, especially in smokers.
PURPOSE: We examined the associations between plasma micronutrients and bladder cancer risk, and evaluated the combined effects of carotenoid and cigarette smoke. MATERIALS AND METHODS: We performed a case-control study in 242 patients with bladder cancer and 204 healthy controls at Memorial Sloan-Kettering Cancer Center from 1993 to 1997. Epidemiological data and blood specimens were collected on 84 cases and 173 controls. Plasma micronutrients, including lutein, zeaxanthin, beta-cryptoxanthin, lycopene, alpha-carotene, beta-carotene, retinol, alpha-tocopherol and gamma-tocopherol, were determined by high performance liquid chromatography. The logistic regression model was used to estimate the effects from carotenoid, tocopherol and retinol on the risk of bladder cancer. RESULTS: Based on quartiles of plasma micronutrient levels and continuous variables, adjusted ORs were estimated for bladder cancer after controlling for potential confounders, including patient age, sex, education and pack-years of smoking. When using plasma levels of micronutrients as continuous variables, the adjusted OR was 0.22 (95% CI 0.05 to 0.92) for alpha-carotene, 0.42 (95% CI 0.18 to 1.00) for lutein, 0.16 (95% CI 0.02 to 1.06) for zeaxanthin, 0.94 (95% CI 0.89 to 0.99) for lycopene and 0.90 (95% CI 0.81 to 1.00) for beta-cryptoxanthin. The adjusted OR for the joint effect of plasma carotenoids and tobacco smoking was 6.22 (95% CI 1.87 to 20.8) in smokers with lower lutein and 5.18 (95% CI 1.57 to 17.1) in smokers with lower zeaxanthin. CONCLUSIONS: Our results show protective effects of carotenoids on bladder cancer. They suggest that bladder cancer may be a preventable disease through nutritional intervention, especially in smokers.
Authors: Sungshim L Park; Delara Bastani; Binh Y Goldstein; Shen-Chih Chang; Wendy Cozen; Lin Cai; Carlos Cordon-Cardo; Baoguo Ding; Sander Greenland; Na He; Shehnaz K Hussain; Qingwu Jiang; Yuan-Chin A Lee; Simin Liu; Ming-Lan Lu; Thomas M Mack; Jenny T Mao; Hal Morgenstern; Li-Na Mu; Sam S Oh; Allan Pantuck; Jeanette C Papp; Jianyu Rao; Victor E Reuter; Donald P Tashkin; Hua Wang; Nai-Chieh Y You; Shun-Zhang Yu; Jin-Kou Zhao; Zuo-Feng Zhang Journal: Carcinogenesis Date: 2010-05-17 Impact factor: 4.944
Authors: Shenghui Wu; Yanning Liu; Joel E Michalek; Ruben A Mesa; Dorothy Long Parma; Ronald Rodriguez; Ahmed M Mansour; Robert Svatek; Thomas C Tucker; Amelie G Ramirez Journal: Adv Nutr Date: 2020-05-01 Impact factor: 8.701
Authors: J Kellogg Parsons; John P Pierce; Loki Natarajan; Vicky A Newman; Leslie Barbier; James Mohler; Cheryl L Rock; Dennis D Heath; Khurshid Guru; Michael B Jameson; Hongying Li; Hossein Mirheydar; Michael A Holmes; James Marshall Journal: Cancer Prev Res (Phila) Date: 2013-07-18
Authors: Ana R Vieira; Snieguole Vingeliene; Doris S M Chan; Dagfinn Aune; Leila Abar; Deborah Navarro Rosenblatt; Darren C Greenwood; Teresa Norat Journal: Cancer Med Date: 2014-12-02 Impact factor: 4.452
Authors: Maree T Brinkman; Margaret R Karagas; Michael Scott Zens; Alan Schned; Raoul C Reulen; Maurice P Zeegers Journal: Cancer Causes Control Date: 2009-12-31 Impact factor: 2.506